Antidepressant-like Effects of BDNF and NGF Individual Loop Dipeptide Mimetics Depend on the Signal Transmission Patterns Associated with Trk
Open Access
- 24 February 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (3) , 284
Abstract
Neurotrophins are considered as an attractive target for the development of antidepressants with a novel mechanism of action. Previously, the dimeric dipeptide mimetics of individual loops of nerve growth factor, NGF (GK-6, loop 1; GK-2, loop 4) and brain-derived neurotrophic factor, BDNF (GSB-214, loop 1; GTS-201, loop 2; GSB-106, loop 4) were designed and synthesized. All the mimetics of NGF and BDNF in vitro after a 5–180 min incubation in a HT-22 cell culture were able to phosphorylate the tropomyosin-related kinase A (TrkA) or B (TrkB) receptors, respectively, but had different post-receptor signaling patterns. In the present study, we conduct comparative research of the antidepressant-like activity of these mimetics at acute and subchronic administration in the forced swim test in mice. Only the dipeptide GSB-106 that in vitro activates mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK), phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) and phospholipase C-gamma (PLCγ) post-receptor pathways exhibited antidepressant-like activity (0.1 and 1.0 mg/kg, ip) at acute administration. At the same time, the inhibition of any one of these signaling pathways completely prevented the antidepressant-like effects of GSB-106 in the forced swim test. All the NGF mimetics were inactive after a single injection regardless of post-receptor in vitro signaling patterns. All the investigated dipeptides, except GTS-201, not activating PI3K/AKT in vitro unlike the other compounds, were active at subchronic administration. The data obtained demonstrate that the low-molecular weight BDNF mimetic GSB-106 that activates all three main post-receptor TrkB signaling pathways is the most promising for the development as an antidepressant.Keywords
Funding Information
- Russian Science Foundation (18-15-00381)
This publication has 68 references indexed in Scilit:
- Decreased mRNA and Protein Expression of BDNF, NGF, and their Receptors in the Hippocampus from Suicide: An Analysis in Human Postmortem BrainClinical Medicine Insights: Pathology, 2013
- Design and synthesis of dipeptide mimetics of the brain-derived neurotrophic factorRussian Journal of Bioorganic Chemistry, 2012
- Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter BlockadePLOS ONE, 2011
- mTOR signaling: At the crossroads of plasticity, memory and diseaseTrends in Neurosciences, 2010
- Nerve growth factor (NGF) has novel antidepressant-like properties in ratsPharmacology Biochemistry and Behavior, 2010
- Inhibition of PI3K-Akt Signaling Blocks Exercise-Mediated Enhancement of Adult Neurogenesis and Synaptic Plasticity in the Dentate GyrusPLOS ONE, 2009
- TrkB Regulates Hippocampal Neurogenesis and Governs Sensitivity to Antidepressive TreatmentNeuron, 2008
- Immunohistochemical Distribution of NGF, BDNF, NT-3, and NT-4 in Adult Rhesus Monkey BrainsJournal of Histochemistry & Cytochemistry, 2007
- Reduced Anxiety and Depression-Like Behaviors in Mice Lacking GABA Transporter Subtype 1Neuropsychopharmacology, 2006
- Neurotrophin-regulated signalling pathwaysPhilosophical Transactions of the Royal Society B: Biological Sciences, 2006